A Wearable Infrared Sensor for Detecting Non-ST Segment Elevation Acute Coronary Syndromes
Partho P Sengupta1, Ankush D Jamthikar1, Naveena Yanamala1
1Division of Cardiovascular Diseases and Hypertension, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
A new infrared biosensor offers a noninvasive method for diagnosing non-ST segment elevation acute coronary syndrome (NSTE-ACS). This bloodless, electrode-free tool accurately predicts coronary obstruction and 30-day adverse outcomes, outperforming traditional risk scores.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Diagnostics
Background:
- Conventional diagnosis of non-ST segment elevation acute coronary syndrome (NSTE-ACS) relies on electrocardiography and blood biomarkers.
- Current diagnostic methods can be invasive and time-consuming.
Purpose of the Study:
- To investigate a noninvasive, bloodless, and electrode-free diagnostic strategy for NSTE-ACS.
- To evaluate a wrist-worn infrared spectrophotometric biosensor (Infrasensor) for early risk stratification.
Main Methods:
- Prospective multicenter study involving 595 patients with suspected NSTE-ACS.
- Utilized a machine learning model with data from a wrist-worn infrared biosensor.
- External validation using a leave-one-cohort-out approach with 200 multi-ethnic controls.
Main Results:
- The primary model detected high-grade coronary obstruction with an AUC of 0.87, 90% specificity, and 84% positive predictive value.
- A secondary model predicted 30-day adverse outcomes with an AUC of 0.89, 99% sensitivity, and 96% negative predictive value.
- Performance surpassed conventional risk scores.
Conclusions:
- The Infrasensor demonstrates high diagnostic accuracy for coronary obstruction and adverse outcome prediction in NSTE-ACS.
- The device shows potential as a rapid, noninvasive point-of-care tool for NSTE-ACS risk stratification.
- Findings support the Infrasensor's utility in a diverse, multicenter setting.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
09:33Using Near-Infrared Spectroscopy Wearable Devices to Identify Central Versus Peripheral Limitations During Exercise
Published on: December 19, 2024
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Holter Monitor: 24-Hour Monitoring
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
